Big Name Drugs Going Generic
If you are currently on a big-name prescription drug with big name costs, you might be in luck! Many of these drugs are losing patent protection, which means that they could be soon facing generic competition. Below is the list of popular drugs scheduled to lose U.S. market protection. (
Found on: http://www.osbornassoc.com/blog/popular_drugs_are_going_off_patent_in_2013_2016)
BRAND NAME |
GENERIC NAME |
CONDITION |
DOSAGE FORM |
ANTICIPATED LAUNCH |
| Mirapex ER® | Pramipexole Dihydrochloride | Parkinson’s Disease | Tablets | First Quarter 2014 |
| Suprane® | Desflurane | General Anesthetic | Inhalation Liquid | First Quarter 2014 |
| Vivelle Dot® | Estradiol | Female Hormone Replacement | Patch | First Quarter 2014 |
| Xeloda® | Capecitabine | Treat Cancer | Tablets | 03-07-2014 |
| Renagel® | Sevelamer Hydrochloride | Phosphate Binder | Tablets | 03-16-2014 |
| Pennsaid® | Diclofenac Sodium | NSAID | Solution | 03-27-2014 |
| Differin® | Adapalene (0.3%) | Treat Acne | Gel | Second Quarter 2014 |
| Rapamune® (1 & 2mg) | Sirolimus | Lowers Immune System | Tablets | Second Quarter 2014 |
| Orapred® | Prednisolone Sod Phod | Steroid | ODT | 04-01-2014 |
| Evista® | Raloxifene | Osteoporosis in Women | Tablets | 04-04-2014 |
| Viracept® | Nelfinavir | Antiviral | Tablets | 04-07-2014 |
| Lunesta® | Eszopiclone | Sedative | Tablets | 04-15-2014 |
| Renvela® | Sevelamer Carbonate | Phosphate Binder | Tablets/Suspension | 04-15-2014 |
| Exalgo® (32mg) | Hydromorphone Hydrochloride | Pain Management | Tablets | 05-15-2014 |
| Travatan Z® | Travoprost | Glaucoma | Solution | June 2014 |
| Diovan® | Valsartan | Lowers Blood Pressure | Tablets | June/July 2014 |
| Actonel® | Risedronate | Slows Bone Loss | Tablets | 06-10-2014 |
| Naprelan® | Naproxen Sodium Controlled Release | NSAID | Tablets | 06-10-2014 |
| Gralise® | Gabapentin | Anticonvulsant | Tablets | 07-20-2014 |
| Renvela® | Sevelamer Carbonate | Phosphate Binder | Suspension/Suspension | September 2014 |
| Nexium® | Esomeprazole | Treats GERD | Capsules | Fourth Quarter 2014 |
| Halflytely® & Biscadoyl® | Polyethylene Glycol/Biscadoyl | Laxative | Tablets | October 2014 |
| Exforge® | Amlodipine/Valsartan | Lowers Blood Pressure | Tablets | 10-01-2014 |
| Intuniv® (1,2,3 & 4mg) | Guanfacine Hydrochloride | Treat ADHD | Tablets | 12-01-2014 |
| Revlimid® | Lenalidomide | Treat Anemia | Capsules | 12-12-2014 |
| Actoplus Met XR® | Metformin Hcl, Pioglitazone Hcl | Diabetes | Tablets | 2015 |
| Lumigan® | Bimatoprost | Glaucoma | Ophthalmic Solution | First/Second Quarter 2015 |
| Welchol® | Colesevelam | Lowers Cholesterol | Tablets | 03-02-2015 |
| Abilify® | Aripiprazole | Antipsychotic | Tablets/ODT/Solution | 04-20-2015 |
| Fazaclo® (150 & 200mg) | Clozapine | Antipsychotic | ODT | 05-01-2015 |
| Zyvox® | Linezolid | Antibiotic | Tablets/Suspension | 05-18-2015 |
| Epipen® | Epinephrine | Anaphylaxis | Injection | 06-22-2015 |
| Aggrenox® | Aspirin/Dipyridamole | Reduces Risk of Stroke | Capsules | 07-01-2015 |
| Targretin® | Bexarotene | Treat Cancer | Capsules | 07-09-2015 |
| Androgel® | Testosterone | Hormone | Gel | 08-31-2015 |
| Avodart® | Dutasteride | Treat Benign Prostatic Hyperplasia | Capsules | Fourth Quarter 2015 |
| Fenoglide® | Fenofibrate | Lowers cholesterol | Tablets/ODT | 10-01-2015 |
| Patanol® | Olopatadine Hydrochloride | Antihistamine | Ophthalmic Solution | 12-06-2015 |
| Ortho Tri-Cyclen Lo® | Ethinyl Estradiol, Norgestimate | Birth Control | Tablets | 12-31-2015 |
| Glumeteza® | Metformin Hcl | Diabetes | Tablets | 02-01-2016 |
| Azilect® | Rasagiline Mesylate | Parkinson’s Disease | Tablets | Fourth Quarter 2016 |
| *Actual launch dates depend on FDA approvals and may change at any time | ||||
Share the post "Big Name Drugs Going Generic"
